Photo Release -- NVN Therapeutics Announces Winner of First Glucorein(TM) PCOS Baby Contest

PCOS One of Most Common Female Endocrine Disorders Affecting One in Ten Women of Reproductive Age

SACRAMENTO, Calif., Sept. 12, 2013 (GLOBE NEWSWIRE) -- NVN Therapeutics ( today announced the winning entry in the company's First Glucorein Baby Contest. Entrants in the contest were women who had found it problematic to conceive due to PCOS, or polycystic ovary syndrome, one of the most common female endocrine disorders affecting one in ten women of reproductive age. It is thought to be one of the leading causes of female infertility.

A photo accompanying this release is available at

"God placed a special friend in my life and I decided to talk to her about my struggle," Candi Marquez wrote of her efforts to become pregnant. "She knew of this wonderful new product and suggested I try Glucorein. I had never heard of it but the fact that it was all-natural had me sold. I began taking it in August of 2012 and the first thing I noticed was my period showed up almost immediately."

Principal symptoms of PCOS include anovulation, resulting in irregular menses, amenorrhea, ovulation-related infertility and polycystic ovaries; excessive amounts of androgenic hormones resulting in acne and unwanted facial/body hair growth; and insulin resistance, often associated with obesity, Type 2 diabetes and high cholesterol levels. The symptoms and severity of the syndrome vary greatly among affected women.

But when Candi's next menses failed to materialize, she was disappointed. Had Glucorein failed her? But then she hoped for the unthinkable. "Or had Glucorein set my body so straight that I had actually conceived? So I nervously took the test. Within moments—and in bright, beautiful letters—the word 'PREGNANT' began flashing at me.  My prayers had been answered.

"A bit dramatic?" Candi continued. "Not at all. If you've ever had to battle PCOS and infertility issues, to find something that doesn't require emptying your savings account or visiting one doctor after another—well, it's nothing short of a blessed miracle. Our son is a simple and wonderful gift. Thank you God and thank you Glucorein."

Contest entries were judged based upon the mother's telling of her experience in becoming pregnant while using Glucorein™ PCOS. Candi won a $500 Babies R Us gift card for the telling of her story.  

"We understand the fertility issue is one of great importance to women afflicted with PCOS," said Susan Derence, director of sales for NVN Therapeutics. "Our team takes great pride in being able to provide aspiring mothers with a product that safely and naturally allows them to bring to fruition one of their greatest aspirations. There is no higher mission." 

NVN Therapeutics' patent-pending Glucorein™ for Polycystic Ovarian Syndrome (PCOS) is patent-pending proprietary blend of chlorogenic acid and L-cysteine, which collectively reduce the incidence of metabolic syndrome and insulin resistance, both thought to be key contributors to PCOS. More information is available at or by phoning 1-888-259-6599.

About NVN Therapeutics

NVN Therapeutics develops and manufactures medical foods, which are natural solutions without compromise. Established in 2011, the company's inaugural line of products will target women's health. The first, Glucorein™ PCOS, intended for the dietary management of polycystic ovary syndrome, is formulated with a clinically proven and patent-pending blend of chlorogenic acid and L-cysteine. The company is headquartered in Sacramento, California. More information can be found at  ;

Media: High-resolution photos are available by phoning (425) 753-2105.

Glucorein(tm) PCOS Baby Contest

Contact Data